Why Eric Cantor Going To Head Big Pharma Is The Swampiest Move Ever
Eric Cantor will become the next head of PhRMA, and the two seem made for each other for all the wrong reasons.
Why The Trump Administration Was Right To End The Medicare Part D Insurer Bailout
The temporary and extralegal bailout that provided billions of dollars in subsidies to insurers cost the program far more than Dems claimed.
How Obamacare Pushes Big Pharma To Overcharge You For Prescriptions
I found out firsthand, big conglomerates—in this case, CVS Health—make profits by keeping the system complicated, bureaucratic, and opaque.